New drug combo aims to tackle bipolar depression and suicidal thoughts
Disease control
AVAILABLE
This study offers NRX-101, a combination of two drugs, to adults aged 18-65 with treatment-resistant bipolar depression and suicidal thoughts. Participants receive the medication from their own psychiatrist and undergo regular check-ins on mood, suicidal ideation, and side effect…
Sponsor: NeuroRx, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC